LXRepair provides a new approach to personalized cancer medicine by developing functional diagnostics based on a unique breakthrough technology: DNA Repair Enzyme Signature analysis.

The French Atomic Energy Commission (CEA) has been studying the impact of radiation on DNA for several decades. This research has resulted in a good understanding of the essential DNA repair mechanisms.
Recently, a set of innovative biomarkers was developed providing a complete functional signature for these mechanisms. This signature is now exploited as part of powerful tools for personalized cancer treatment.

LXRepair is a CEA spin-off building on over 25 years' research into the science behind DNA repair mechanisms and in vitro diagnostics for cancer.

Visit website

Learn more

Secure your next year's bioinformatics support in advance to get the best prices!